Skip to main content
. 2012 Sep 11;23(3):652–663. doi: 10.1016/j.devcel.2012.07.010

Table 1.

Incidence of Specific Anomalies Observed in MozΔ/Δ Mutant Neonatal Mice Compared to Incidence Reported in Patients with DGS and Tbx1 Mouse Mutants

Finding MozΔ/Δ Mouse Neonatesa
Patients with DGS (%)b
Mouse Neonates within a Series of Tbx1 Mutant Alleles (%)c
Number/Total % Botto et al. (2003) Kobrynski and Sullivan (2007) / Neo/Neo /Neo2 Neo2/Neo Neo2/Neo2 +/ +/Neo +/Neo2
Any major finding 33/33 100 100 100 100 100 100 100
Palatal anomalies 33/33 100 16 69–100 100 0
Cleft bony palate 33/33 100 11 100 0
Absent or hypoplastic thymus 33/33 100 28 100 100 100 41 29
Skeletal 33/33 100 9 17–19 100
Vertebrae anomalies 33/33 100 7 19 100
Cardiovascular defects 19/19 100 81 49–83 100
Cardiac defects 18/19 95 100 100 100 85
Ventricular septum defect 18/19 95 69 30–36 100 100 100 85
Atrioventricular septum defect 3/12 25 3
Aortic arch defects 14/19 74 63 100 100 90 100 38 42 11
Interrupted aortic arch 14/19 74 23 14–15 87 20 3 0
Right descending aorta 5/19 26 43 13
a

Data are derived from this study.

b

Data are derived from Botto et al. (2003), who examined 35 patients with DGS (43 with respect to some findings), and Kobrynski and Sullivan (2007), who summarized data from multiple sources. Note the high degree of variation among patients with DGS.

c

Data are derived from Jerome and Papaioannou (2001), Vitelli et al. (2002), Xu et al. (2004), and Zhang and Baldini (2008). Tbx1 mRNA ranges from 0% in the Tbx1−/− to 70% of wild type in the Tbx1+/Neo2. √ indicates that defect is present but penetrance not stated. – indicates t hat no data are available.

HHS Vulnerability Disclosure